Stocks
Hologic Financial Statements (HOLX) |
||||||||||
| Hologicsmart-lab.ru | % | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q2 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 30.09.2023 | 21.11.2023 | 02.02.2024 | 02.05.2024 | 03.05.2024 | 03.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 945.3 | 945.3 | 1 013 | 1 018 | 1 018 | 3 994 | |||
| Operating Income, bln rub | 132.5 | 132.5 | 198.2 | 210.4 | 243.3 | 784.4 | ||||
| EBITDA, bln rub | ? | 305.5 | 305.5 | 198.2 | 210.4 | 317.0 | 1 031 | |||
| Net profit, bln rub | ? | 90.6 | 90.6 | 246.5 | 169.9 | 169.9 | 676.9 | |||
| OCF, bln rub | ? | 258.7 | 258.7 | 220.0 | 0.000 | 292.4 | 771.1 | |||
| CAPEX, bln rub | ? | 52.5 | 52.5 | 38.0 | 0.000 | 28.0 | 118.5 | |||
| FCF, bln rub | ? | 206.2 | 206.2 | 182.0 | 0.000 | 264.4 | 652.6 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 311.5 | 311.5 | 340.8 | 331.9 | 319.2 | 1 303 | ||||
| Cost of production, bln rub | 445.0 | 445.0 | 445.6 | 475.5 | 455.3 | 1 821 | ||||
| R&D, bln rub | 72.9 | 72.9 | 66.8 | 74.6 | 74.6 | 288.9 | ||||
| Interest expenses, bln rub | 28.1 | 28.1 | 26.0 | 32.3 | 32.3 | 118.7 | ||||
| Assets, bln rub | 9 139 | 9 139 | 8 470 | 8 714 | 8 714 | 8 714 | ||||
| Net Assets, bln rub | ? | 5 017 | 5 017 | 4 654 | 4 844 | 4 844 | 4 844 | |||
| Debt, bln rub | 2 818 | 2 818 | 2 578 | 2 552 | 2 569 | 2 569 | ||||
| Cash, bln rub | 2 723 | 2 723 | 1 932 | 2 180 | 2 180 | 2 180 | ||||
| Net debt, bln rub | 95.7 | 95.7 | 645.9 | 371.5 | 388.5 | 388.5 | ||||
| Ordinary share price, rub | 69.4 | 69.4 | 71.5 | 78.0 | 78.0 | 66.6 | ||||
| Number of ordinary shares, mln | 245.1 | 245.1 | 238.6 | 235.9 | 235.9 | 235.9 | ||||
| Market cap, bln rub | 17 012 | 17 012 | 17 050 | 18 390 | 18 390 | 15 701 | ||||
| EV, bln rub | ? | 17 108 | 17 108 | 17 696 | 18 761 | 18 778 | 16 089 | |||
| Book value, bln rub | 5 017 | 847 | 515 | 4 844 | 800 | 800 | ||||
| EPS, rub | ? | 0.37 | 0.37 | 1.03 | 0.72 | 0.72 | 2.87 | |||
| FCF/share, rub | 0.84 | 0.84 | 0.76 | 0.00 | 1.12 | 2.77 | ||||
| BV/share, rub | 20.5 | 3.46 | 2.16 | 20.5 | 3.39 | 3.39 | ||||
| EBITDA margin, % | ? | 32.3% | 32.3% | 19.6% | 20.7% | 31.1% | 25.8% | |||
| Net margin, % | ? | 9.58% | 9.58% | 24.3% | 16.7% | 16.7% | 16.9% | |||
| FCF yield, % | ? | 6.61% | 6.61% | 5.04% | 3.72% | 5.16% | 4.16% | |||
| ROE, % | ? | 12.8% | 12.8% | 11.1% | 9.63% | 9.63% | 14.0% | |||
| ROA, % | ? | 7.04% | 7.04% | 6.08% | 5.35% | 5.35% | 7.77% | |||
| P/E | ? | 26.4 | 26.4 | 33.1 | 39.4 | 39.4 | 23.2 | |||
| P/FCF | 82.5 | 15.1 | 19.9 | 26.9 | 19.4 | 24.1 | ||||
| P/S | ? | 3.33 | 3.33 | 4.30 | 4.64 | 4.64 | 3.93 | |||
| P/BV | ? | 3.39 | 20.1 | 33.1 | 3.80 | 23.0 | 19.6 | |||
| EV/EBITDA | ? | 11.0 | 11.0 | 16.9 | 21.3 | 19.0 | 15.6 | |||
| Debt/EBITDA | 0.06 | 0.06 | 0.62 | 0.42 | 0.39 | 0.38 | ||||
| R&D/CAPEX, % | 138.9% | 138.9% | 175.8% | 266.4% | 243.8% | |||||
| CAPEX/Revenue, % | 5.55% | 5.55% | 3.75% | 0.00% | 2.75% | 2.97% | ||||
| Hologic shareholders | ||||||||||
